{
    "organizations": [],
    "uuid": "a706e8f2d4a02027027d32f5a86b7325717b0181",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/02/20/globe-newswire-amag-pharmaceuticals-to-host-fourth-quarter-and-full-year-2017-financial-results-conference-call-and-webcast-on-tuesday.html",
    "ord_in_thread": 0,
    "title": "AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast on Tuesday, February 27, 2018 at 8:00 a.m. ET",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "WALTHAM, Mass., AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that its fourth quarter and full year 2017 financial results will be released on Tuesday, February 27, 2018 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.\nDial-in Number\nU.S./Canada Dial-in Number: (877) 412-6083\nInternational Dial-in Number: (702) 495-1202\nConference ID: 5496159\nReplay Dial-in Number: (855) 859-2056\nReplay International Dial-in Number: (404) 537-3406\nConference ID: 5496159\nA telephone replay will be available from approximately 11:00 a.m. ET on February 27, 2018 through midnight on March 5, 2018.\nThe webcast with slides will be accessible through the Investors section of the company’s website at www.amagpharma.com . A replay of the webcast will be archived on the website for 30 days.\nAbout AMAG\nAMAG is a biopharmaceutical company focused on developing and delivering important therapeutics, conducting clinical research in areas of unmet need and creating education and support programs for the patients and families we serve. Our currently marketed products support the health of patients in the areas of maternal and women’s health, anemia management and cancer supportive care. Through CBR®, we also help families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit www.amagpharma.com .\nAMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. CBR® is a registered trademark of Cbr Systems, Inc.\nAMAG Pharmaceuticals Contact:\nChristi Waarich\nAssociate Director, Investor Relations\n617-498-7638\nSource:AMAG Pharmaceuticals, Inc.",
    "published": "2018-02-20T16:00:00.000+02:00",
    "crawled": "2018-02-20T17:31:24.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "waltham",
        "amag",
        "pharmaceutical",
        "nasdaq",
        "amag",
        "today",
        "announced",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "released",
        "tuesday",
        "february",
        "financial",
        "market",
        "open",
        "management",
        "host",
        "conference",
        "call",
        "webcast",
        "et",
        "discus",
        "result",
        "provide",
        "update",
        "recent",
        "corporate",
        "development",
        "number",
        "number",
        "international",
        "number",
        "conference",
        "id",
        "replay",
        "number",
        "replay",
        "international",
        "number",
        "conference",
        "id",
        "telephone",
        "replay",
        "available",
        "approximately",
        "et",
        "february",
        "midnight",
        "march",
        "webcast",
        "slide",
        "accessible",
        "investor",
        "section",
        "company",
        "website",
        "replay",
        "webcast",
        "archived",
        "website",
        "day",
        "amag",
        "amag",
        "biopharmaceutical",
        "company",
        "focused",
        "developing",
        "delivering",
        "important",
        "therapeutic",
        "conducting",
        "clinical",
        "research",
        "area",
        "unmet",
        "need",
        "creating",
        "education",
        "support",
        "program",
        "patient",
        "family",
        "serve",
        "currently",
        "marketed",
        "product",
        "support",
        "health",
        "patient",
        "area",
        "maternal",
        "woman",
        "health",
        "anemia",
        "management",
        "cancer",
        "supportive",
        "care",
        "also",
        "help",
        "family",
        "preserve",
        "newborn",
        "stem",
        "cell",
        "used",
        "today",
        "transplant",
        "medicine",
        "certain",
        "cancer",
        "blood",
        "immune",
        "metabolic",
        "disorder",
        "potential",
        "play",
        "valuable",
        "role",
        "ongoing",
        "development",
        "regenerative",
        "medicine",
        "additional",
        "company",
        "information",
        "please",
        "visit",
        "amag",
        "registered",
        "trademark",
        "amag",
        "pharmaceutical",
        "registered",
        "trademark",
        "cbr",
        "system",
        "amag",
        "pharmaceutical",
        "contact",
        "christi",
        "waarich",
        "associate",
        "director",
        "investor",
        "relation",
        "source",
        "amag",
        "pharmaceutical",
        "inc"
    ]
}